A citation-based method for searching scientific literature

Christoph Wanner, John M Lachin, Silvio E Inzucchi, David Fitchett, Michaela Mattheus, Jyothis George, Hans J Woerle, Uli C Broedl, Maximilian von Eynatten, Bernard Zinman. Circulation 2018
Times Cited: 215



Eri T Kato, Michael G Silverman, Ofri Mosenzon, Thomas A Zelniker, Avivit Cahn, Remo H M Furtado, Julia Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding, Marc P Bonaca, Christian T Ruff, Akshay S Desai, Shinya Goto, Peter A Johansson, Ingrid Gause-Nilsson, Per Johanson, Anna Maria Langkilde, Itamar Raz, Marc S Sabatine, Stephen D Wiviott. Circulation 2019
Times Cited: 225




List of shared articles



Times cited

Effects of Dapagliflozin on Cardiovascular Events, Death, and Safety Outcomes in Patients with Heart Failure: A Meta-Analysis.
Xiao-Dong Zheng, Qiang Qu, Xing-Yu Jiang, Zhong-Yuan Wang, Cheng Tang, Jin-Yu Sun. Am J Cardiovasc Drugs 2021
2

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Diabetes 2021
5

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Hiddo J L Heerspink, Tom Manley, Darren K McGuire, Mark E Molitch, Amy K Mottl,[...]. Am J Kidney Dis 2021
12

SGLT2-inhibitors; more than just glycosuria and diuresis.
Amir Fathi, Keeran Vickneson, Jagdeep S Singh. Heart Fail Rev 2021
6

Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial.
Jasper Tromp, Piotr Ponikowski, Afshin Salsali, Christiane E Angermann, Jan Biegus, Jon Blatchford, Sean P Collins, João Pedro Ferreira, Claudia Grauer, Mikhail Kosiborod,[...]. Eur J Heart Fail 2021
7

Sodium-glucose transporter inhibition in heart failure: from an unexpected side effect to a novel treatment possibility.
Giulia Ferrannini, Gianluigi Savarese, Lars Rydén. Diabetes Res Clin Pract 2021
1

Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Thomas A Zelniker, Itamar Raz, Ofri Mosenzon, Jamie P Dwyer, Hiddo H J L Heerspink, Avivit Cahn, Erica L Goodrich, Kyungah Im, Deepak L Bhatt, Lawrence A Leiter,[...]. JAMA Cardiol 2021
0


Sodium-glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review.
Roy Rasalam, John J Atherton, Gary Deed, Michael Molloy-Bland, Neale Cohen, Andrew Sindone. ESC Heart Fail 2021
1

CARDIOVASCULAR EFFECTS OF NON-INSULIN GLUCOSE-LOWERING AGENTS: A COMPREHENSIVE REVIEW OF TRIAL EVIDENCE AND POTENTIAL CARDIOPROTECTIVE MECHANISMS.
Gianluigi Savarese, Javed Butler, Lars H Lund, Deepak L Bhatt, Stefan D Anker. Cardiovasc Res 2021
1

Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.
Takayoshi Kanie, Atsushi Mizuno, Yoshimitsu Takaoka, Takahiro Suzuki, Daisuke Yoneoka, Yuri Nishikawa, Wilson Wai San Tam, Jakub Morze, Andrzej Rynkiewicz, Yiqiao Xin,[...]. Cochrane Database Syst Rev 2021
0


Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Clare Arnott, Qiang Li, Amy Kang, Brendon L Neuen, Severine Bompoint, Carolyn S P Lam, Anthony Rodgers, Kenneth W Mahaffey, Christopher P Cannon, Vlado Perkovic,[...]. J Am Heart Assoc 2020
75




Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus: Part 2.
Srikanth Yandrapalli, Aaqib Malik, Adam Horblitt, Gayatri Pemmasani, Wilbert S Aronow, William H Frishman. Cardiol Rev 2020
3

Sodium-Glucose Co-transporter 2 Inhibitors in the Failing Heart: a Growing Potential.
Dulce Brito, Paulo Bettencourt, Davide Carvalho, Jorge Ferreira, Ricardo Fontes-Carvalho, Fátima Franco, Brenda Moura, José Carlos Silva-Cardoso, Rachel Tavares de Melo, Cândida Fonseca. Cardiovasc Drugs Ther 2020
4

Reappraisal on pharmacological and mechanical treatments of heart failure.
Bo Liang, Yu-Xiu Zhao, Xiao-Xiao Zhang, Hui-Ling Liao, Ning Gu. Cardiovasc Diabetol 2020
6

Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door.
Alberto Palazzuoli, Gaetano Ruocco, Edoardo Gronda. Heart Fail Rev 2020
0